#Denmark #Copenhagen #Novartis #Dawn Health #Cora BC

Supporting Breast Cancer Patients: The Launch of Cora BC

In a landmark collaboration, Dawn Health and Novartis have unveiled the Cora BC app, an innovative digital resource aimed at supporting individuals diagnosed with breast cancer. This launch marks a significant step forward in alleviating the challenges that accompany a breast cancer diagnosis and treatment.

Breast cancer not only impacts a patient’s physical well-being but also imposes significant mental and emotional challenges. The complexities of managing various therapies, dealing with side effects, and maintaining communication with healthcare professionals can be overwhelming. Acknowledging these daunting experiences, Dawn Health introduces Cora BC to simplify and enhance the patient journey.

What is Cora BC?

Cora BC is a user-friendly app designed to provide comprehensive support to breast cancer patients, regardless of their treatment stage. It empowers users to track their health effectively, offering insights that foster a better understanding of their personal journeys. Through regular health check-ins and visual progress visualization via intuitive graphs, patients can gain clarity on their conditions and feel more in control of their treatment pathways.

Equipping patients with tools such as personalized medication reminders and appointment notifications, Cora BC focuses on nurturing healthy habits, thereby helping users adhere to their multi-year treatment plans. This tailored approach addresses the individual needs of each patient, recognizing that everyone’s journey through cancer is unique.

Features of Cora BC

Cora BC isn’t just a tracking app; it is a holistic system that combines health monitoring with educational resources. Featuring curated, personalized content, the app provides patients with relevant information tailored to their specific circumstances. From addressing common queries to offering actionable advice, Cora BC serves as a vital resource at critical times.

Beyond its educational capabilities, the app also promotes organization amongst users. Through diary entries and preparation tools for upcoming medical consultations, Cora BC enables more structured and informed discussions with healthcare providers.

As Alexander Mandix Hansen, CEO of Dawn Health, aptly states, "Cora BC is more than a tool—it's a step toward better care." This initiative reflects a shared commitment between Dawn Health and Novartis to advance patient-centered care and ensure that breast cancer patients have the necessary resources to enhance their health outcomes.

Expansion Plans

Cora BC will initially launch in Germany, with plans to expand into the UK, Canada, Australia, and additional markets. While it does not intend to replace professional medical advice, diagnosis, or treatment recommendations, Cora BC acts as a powerful ally by organizing care and strengthening communication between patients and their healthcare teams.

This launch follows a successful partnership between Dawn Health and Novartis, previously demonstrated through projects such as Ekiva MS and Ekiva PNH. It further highlights the potential of digital health initiatives in transforming chronic care management and improving patient experiences.

For more details about Cora BC, please visit cora-bc.com.

About Dawn Health

Dawn Health is at the forefront of the digital health revolution, specializing in software as a medical device (SaMD) and digital therapeutics (DTx). The company’s commitment to accelerating the launch of innovative solutions aims to make a significant impact on the lives of individuals coping with chronic health conditions. By fostering close collaborations within the life sciences industry, Dawn Health creates transformative digital health products that center around empathy and patient care.